Cancer Association Study of Aminoacyl-tRNA Synthetase Signaling Network in Glioblastoma

PLoS ONE

Volumn 7, Issue 8, 2012, Pages

  Kim, Yong Wan ^a   Kwon, ChangHyuk ^b   Liu, Juinn Lin ^c   Kim, Se Hoon ^d   Kim, Sunghoon ^e  

^a The Catholic University of Korea   (South Korea)

^b Seoul National University College of Medicine   (South Korea)

^c UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^d Yonsei University College of Medicine   (South Korea)

^e Seoul National University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATE; ADENOSINE TRIPHOSPHATE 5C1; AMINO ACID TRANSFER RNA LIGASE; AMINOACYL TRANSFER RNA SYNTHETASE MULTIFUNCTIONAL PROTEIN; HEAT SHOCK PROTEIN; HEAT SHOCK PROTEIN 90AA1; HERMES ANTIGEN; RETINOID X RECEPTOR BETA; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 2; UNCLASSIFIED DRUG;

AGE; ARTICLE; BRAIN CANCER; BREAST CANCER; CANCER PATIENT; CANCER PROGNOSIS; CANCER SURVIVAL; COLON CANCER; CORRELATION ANALYSIS; GENE EXPRESSION PROFILING; GENETIC ASSOCIATION; GENETIC REGULATION; GLIOBLASTOMA; HEMATOLOGIC MALIGNANCY; HUMAN; HUMAN TISSUE; KIDNEY CANCER; LIVER CANCER; LUNG CANCER; LYMPHOMA; MAJOR CLINICAL STUDY; MOLECULAR PROBE; ONCOGENE; PHENOTYPE; PROSTATE CANCER; PROTEIN ANALYSIS; SIGNAL TRANSDUCTION; STOMACH CANCER; UTERINE CERVIX CANCER;

AMINO ACYL-TRNA SYNTHETASES; BRAIN NEOPLASMS; CELL LINE, TUMOR; CLUSTER ANALYSIS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; GENOME, HUMAN; GLIOBLASTOMA; HUMANS; NEOPLASMS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PHENOTYPE; PROGNOSIS; PROTEIN INTERACTION MAPPING; SIGNAL TRANSDUCTION; TWO-HYBRID SYSTEM TECHNIQUES;

EID: 84865623601     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0040960     Document Type: Article

References (51)

1. Kim S, You S, Hwang D, (2011) Aminoacyl-tRNA synthetases and tumorigenesis: more than housekeeping. Nat Rev Cancer 11: 708-718.
2. Kushner JP, Boll D, Quagliana J, Dickman S, (1976) Elevated methionine-tRNA synthetase activity in human colon cancer. Proc Soc Exp Biol Med 153: 273-276.
3. Park SG, Kim HJ, Min YH, Choi EC, Shin YK, et al. (2005) Human lysyl-tRNA synthetase is secreted to trigger proinflammatory response. Proc Natl Acad Sci U S A 102: 6356-6361.
4. Wasenius VM, Hemmer S, Kettunen E, Knuutila S, Franssila K, et al. (2003) Hepatocyte growth factor receptor, matrix metalloproteinase-11, tissue inhibitor of metalloproteinase-1, and fibronectin are up-regulated in papillary thyroid carcinoma: a cDNA and tissue microarray study. Clin Cancer Res 9: 68-75.
5. Scandurro AB, Weldon CW, Figueroa YG, Alam J, Beckman BS, (2001) Gene microarray analysis reveals a novel hypoxia signal transduction pathway in human hepatocellular carcinoma cells. Int J Oncol 19: 129-135.
6. Pasternak K, (1997) Extracellular presence of aminoacyl-tRNA synthetases. Ann Univ Mariae Curie Sklodowska Med 52: 29-38.
7. Jordanova A, Irobi J, Thomas FP, Van Dijck P, Meerschaert K, et al. (2006) Disrupted function and axonal distribution of mutant tyrosyl-tRNA synthetase in dominant intermediate Charcot-Marie-Tooth neuropathy. Nat Genet 38: 197-202.
8. Ray PS, Fox PL, (2007) A post-transcriptional pathway represses monocyte VEGF-A expression and angiogenic activity. EMBO J 26: 3360-3372.
9. Tzima E, Schimmel P, (2006) Inhibition of tumor angiogenesis by a natural fragment of a tRNA synthetase. Trends Biochem Sci 31: 7-10.
10. Vellaichamy A, Sreekumar A, Strahler JR, Rajendiran T, Yu J, et al. (2009) Proteomic interrogation of androgen action in prostate cancer cells reveals roles of aminoacyl tRNA synthetases. PLoS One 4: e7075.
11. Reifenberger G, Ichimura K, Reifenberger J, Elkahloun AG, Meltzer PS, et al. (1996) Refined mapping of 12q13-q15 amplicons in human malignant gliomas suggests CDK4/SAS and MDM2 as independent amplification targets. Cancer Res 56: 5141-5145.
12. Cavenee WK, (2002) Genetics and new approaches to cancer therapy. Carcinogenesis 23: 683-686.
13. Suh KS, Park SW, Castro A, Patel H, Blake P, et al. (2010) Ovarian cancer biomarkers for molecular biosensors and translational medicine. Expert Rev Mol Diagn 10: 1069-1083.
14. Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature 455: 1061-1068.
15. Phillips HS, Kharbanda S, Chen R, Forrest WF, Soriano RH, et al. (2006) Molecular subclasses of high-grade glioma predict prognosis, delineate a pattern of disease progression, and resemble stages in neurogenesis. Cancer Cell 9: 157-173.
16. Li A, Walling J, Ahn S, Kotliarov Y, Su Q, et al. (2009) Unsupervised analysis of transcriptomic profiles reveals six glioma subtypes. Cancer Res 69: 2091-2099.
17. Guo M, Yang XL, Schimmel P, (2010) New functions of aminoacyl-tRNA synthetases beyond translation. Nat Rev Mol Cell Biol 11: 668-674.
18. Antonellis A, Green ED, (2008) The role of aminoacyl-tRNA synthetases in genetic diseases. Annu Rev Genomics Hum Genet 9: 87-107.
19. Park SG, Schimmel P, Kim S, (2008) Aminoacyl tRNA synthetases and their connections to disease. Proc Natl Acad Sci U S A 105: 11043-11049.
20. Yannay-Cohen N, Carmi-Levy I, Kay G, Yang CM, Han JM, et al. (2009) LysRS serves as a key signaling molecule in the immune response by regulating gene expression. Mol Cell 34: 603-611.
21. Kayton ML, Libutti SK, (2001) Endothelial monocyte activating polypeptide II (EMAP II) enhances the effect of TNF on tumor-associated vasculature. Curr Opin Investig Drugs 2: 136-138.
22. Ko YG, Park H, Kim T, Lee JW, Park SG, et al. (2001) A cofactor of tRNA synthetase, p43, is secreted to up-regulate proinflammatory genes. J Biol Chem 276: 23028-23033.
23. Mathews MB, Reichlin M, Hughes GR, Bernstein RM, (1984) Anti-threonyl-tRNA synthetase, a second myositis-related autoantibody. J Exp Med 160: 420-434.
24. Christodoulou K, Kyriakides T, Hristova AH, Georgiou DM, Kalaydjieva L, et al. (1995) Mapping of a distal form of spinal muscular atrophy with upper limb predominance to chromosome 7p. Hum Mol Genet 4: 1629-1632.
25. Kim S (2011) Novel uses of GRS proteins or fragments thereof. PCT/KR09/05829 ed. Korea: SNU R&DB Foundation.
26. Park MC, Kang T, Jin D, Han JM, Kim SB, et al. (2012) Secreted human glycyl-tRNA synthetase implicated in defense against ERK-activated tumorigenesis. Proc Natl Acad Sci U S A 109: E640-647.
27. Obayashi T, Kinoshita K, (2009) Rank of correlation coefficient as a comparable measure for biological significance of gene coexpression. DNA Res 16: 249-260.
28. Abel TW, Clark C, Bierie B, Chytil A, Aakre M, et al. (2009) GFAP-Cre-mediated activation of oncogenic K-ras results in expansion of the subventricular zone and infiltrating glioma. Mol Cancer Res 7: 645-653.
29. Huttner AJ, Kieran MW, Yao X, Cruz L, Ladner J, et al. (2010) Clinicopathologic study of glioblastoma in children with neurofibromatosis type 1. Pediatr Blood Cancer 54: 890-896.
30. Micallef J, Taccone M, Mukherjee J, Croul S, Busby J, et al. (2009) Epidermal growth factor receptor variant III-induced glioma invasion is mediated through myristoylated alanine-rich protein kinase C substrate overexpression. Cancer Res 69: 7548-7556.
31. Bogdahn U, Hau P, Stockhammer G, Venkataramana NK, Mahapatra AK, et al. (2011) Targeted therapy for high-grade glioma with the TGF-beta2 inhibitor trabedersen: results of a randomized and controlled phase IIb study. Neuro Oncol 13: 132-142.
32. Zheng H, Ying H, Yan H, Kimmelman AC, Hiller DJ, et al. (2008) p53 and Pten control neural and glioma stem/progenitor cell renewal and differentiation. Nature 455: 1129-1133.
33. Brennan C, Momota H, Hambardzumyan D, Ozawa T, Tandon A, et al. (2009) Glioblastoma subclasses can be defined by activity among signal transduction pathways and associated genomic alterations. PLoS One 4: e7752.
34. Gursel DB, Shin BJ, Burkhardt JK, Kesavabhotla K, Schlaff CD, et al. (2011) Glioblastoma Stem-Like Cells-Biology and Therapeutic Implications. Cancers (Basel) 3: 2655-2666.
35. Frank I, Blute ML, Cheville JC, Lohse CM, Weaver AL, et al. (2003) A multifactorial postoperative surveillance model for patients with surgically treated clear cell renal cell carcinoma. J Urol 170: 2225-2232.
36. Patard JJ, Kim HL, Lam JS, Dorey FJ, Pantuck AJ, et al. (2004) Use of the University of California Los Angeles integrated staging system to predict survival in renal cell carcinoma: an international multicenter study. J Clin Oncol 22: 3316-3322.
37. Vasselli JR, Shih JH, Iyengar SR, Maranchie J, Riss J, et al. (2003) Predicting survival in patients with metastatic kidney cancer by gene-expression profiling in the primary tumor. Proc Natl Acad Sci U S A 100: 6958-6963.
38. Zanzoni A, Soler-Lopez M, Aloy P, (2009) A network medicine approach to human disease. FEBS Lett 583: 1759-1765.
39. Cerami E, Demir E, Schultz N, Taylor BS, Sander C, (2010) Automated network analysis identifies core pathways in glioblastoma. PLoS One 5: e8918.
40. Ladha J, Donakonda S, Agrawal S, Thota B, Srividya MR, et al. (2010) Glioblastoma-specific protein interaction network identifies PP1A and CSK21 as connecting molecules between cell cycle-associated genes. Cancer Res 70: 6437-6447.
41. Ducray F, Idbaih A, de Reynies A, Bieche I, Thillet J, et al. (2008) Anaplastic oligodendrogliomas with 1p19q codeletion have a proneural gene expression profile. Mol Cancer 7: 41.
42. Anderson LL, Mao X, Scott BA, Crowder CM, (2009) Survival from hypoxia in C. elegans by inactivation of aminoacyl-tRNA synthetases. Science 323: 630-633.
43. Arsham AM, Neufeld TP, (2009) A genetic screen in Drosophila reveals novel cytoprotective functions of the autophagy-lysosome pathway. PLoS One 4: e6068.
44. Shannon P, Markiel A, Ozier O, Baliga NS, Wang JT, et al. (2003) Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res 13: 2498-2504.
45. Gemma A, Li C, Sugiyama Y, Matsuda K, Seike Y, et al. (2006) Anticancer drug clustering in lung cancer based on gene expression profiles and sensitivity database. BMC Cancer 6: 174.
46. Scherf U, Ross DT, Waltham M, Smith LH, Lee JK, et al. (2000) A gene expression database for the molecular pharmacology of cancer. Nat Genet 24: 236-244.
47. Weinstein JN, Myers TG, O'Connor PM, Friend SH, Fornace AJ Jr, et al. (1997) An information-intensive approach to the molecular pharmacology of cancer. Science 275: 343-349.
48. Hjelmeland AB, Wu Q, Wickman S, Eyler C, Heddleston J, et al. (2010) Targeting A20 decreases glioma stem cell survival and tumor growth. PLoS Biol 8: e1000319.
49. Verhaak RG, Hoadley KA, Purdom E, Wang V, Qi Y, et al. (2010) Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1. Cancer Cell 17: 98-110.
50. Pletcher SD, Macdonald SJ, Marguerie R, Certa U, Stearns SC, et al. (2002) Genome-wide transcript profiles in aging and calorically restricted Drosophila melanogaster. Curr Biol 12: 712-723.
51. Wang JL, Lin YW, Chen HM, Kong X, Xiong H, et al. (2011) Calcium prevents tumorigenesis in a mouse model of colorectal cancer. PLoS One 6: e22566.